These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6223730)

  • 1. Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity.
    Scott CF; Spitler LE
    Clin Exp Immunol; 1983 Jul; 53(1):133-9. PubMed ID: 6223730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulatory T-cells and lymphocytotoxic antibodies in active multiple sclerosis: weekly analysis over a six-month period.
    Hauser SL; Reinherz EL; Hoban CJ; Schlossman SF; Weiner HL
    Ann Neurol; 1983 Apr; 13(4):418-25. PubMed ID: 6220668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood multiple sclerosis: clinical features and demonstration of changes in T cell subsets with disease activity.
    Hauser SL; Bresnan MJ; Reinherz EL; Weiner HL
    Ann Neurol; 1982 May; 11(5):463-8. PubMed ID: 6213188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD16+ gammadelta T cells mediate antibody dependent cellular cytotoxicity: potential mechanism in the pathogenesis of multiple sclerosis.
    Chen Z; Freedman MS
    Clin Immunol; 2008 Aug; 128(2):219-27. PubMed ID: 18501678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor T cells are activated in vivo in patients with multiple sclerosis coinciding with remission from acute attack.
    Huddlestone JR; Oldstone MB
    J Immunol; 1982 Sep; 129(3):915-7. PubMed ID: 6213712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor T-lymphocytes in multiple sclerosis: analysis of patients with acute relapsing and chronic progressive disease.
    Paty DW; Kastrukoff L; Morgan N; Hiob L
    Ann Neurol; 1983 Oct; 14(4):445-9. PubMed ID: 6227277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies.
    Reinherz EL; Weiner HL; Hauser SL; Cohen JA; Distaso JA; Schlossman SF
    N Engl J Med; 1980 Jul; 303(3):125-9. PubMed ID: 6446039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta 2 microglobulin binding activity associated with lymphocytotoxic antibodies in sera containing multiple autoantibodies.
    Barnes RM; Steen S; Kenton P
    J Clin Lab Immunol; 1984 Jul; 14(3):135-40. PubMed ID: 6384521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between antibody-induced modulation of suppressor cells and suppressor cell changes in multiple sclerosis.
    Antel JP; Oger JJ; Arnason BG
    Trans Am Neurol Assoc; 1981; 106():233-6. PubMed ID: 6217621
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease.
    James SP; Neckers LM; Graeff AS; Cossman J; Balch CM; Strober W
    Gastroenterology; 1984 Jun; 86(6):1510-8. PubMed ID: 6232165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cold reactive lymphocytotoxic antibodies in malaria.
    Gilbreath MJ; Pavanand K; MacDermott RP; Wells RA; Ussery MA
    Clin Exp Immunol; 1983 Feb; 51(2):232-8. PubMed ID: 6340870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical disorders associated with T cell subset abnormalities.
    Siegel RL
    Adv Pediatr; 1984; 31():447-80. PubMed ID: 6240196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased frequency of lymphocytotoxic antibodies in patients with multiple sclerosis correlated with disease activity.
    Tsukamoto T; Ebina T; Takase S; Itahara K; Ishida N
    Tohoku J Exp Med; 1982 Feb; 136(2):121-8. PubMed ID: 6978555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytotoxic and monocytotoxic antibodies in the serum and cerebrospinal fluid of multiple sclerosis patients.
    Rumbach L; Tongio MM; Warter JM; Marescaux C; Mayer S; Rohmer F
    J Neuroimmunol; 1982 Dec; 3(4):263-73. PubMed ID: 6983528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological aspects of multiple sclerosis. II. Characterization of antilymphocyte antibodies].
    Scheimberg MA; Tilbery CP
    Rev Paul Med; 1987; 105(3):143-5. PubMed ID: 3502427
    [No Abstract]   [Full Text] [Related]  

  • 17. Depletion of T-lymphocyte subsets using monoclonal antibody and complement: effect on T-colony formation.
    McCluskey DR; Kelly GJ; Morris TC; Bridges JM
    Int J Cell Cloning; 1984 Sep; 2(5):296-303. PubMed ID: 6238108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies.
    Berrih S; Gaud C; Bach MA; Le Brigand H; Binet JP; Bach JF
    Clin Exp Immunol; 1981 Jul; 45(1):1-8. PubMed ID: 6458432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low T8 antigen density on lymphocytes in active multiple sclerosis.
    Reder AT; Antel JP; Oger JJ; McFarland TA; Rosenkoetter M; Arnason BG
    Ann Neurol; 1984 Aug; 16(2):242-9. PubMed ID: 6236742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cold reactive lymphocytotoxic antibodies in pulmonary tuberculosis: correlation with disease activity and HLA.
    Rajalingam R; Mehra NK; Jain RC
    Indian J Exp Biol; 2000 Jul; 38(7):643-50. PubMed ID: 11215305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.